Morgan Lewis represented Idera Pharmaceuticals Inc. in the transaction. Idera Pharmaceuticals Inc., a Pennsylvania-based clinical-stage biopharmaceutical company, entered into an agreement with a fund affiliated with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
